FOREFRONT ANALYTICS, LLC Poseida Therapeutics, Inc. Transaction History

FOREFRONT ANALYTICS, LLC portfolio value:

$59,000
portfolio value

FOREFRONT ANALYTICS, LLC quarter portfolio value change:

+36.82%
quarter

Poseida Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -33.03% -7.72K shares -2K $3.53 15.65K
Q2 2022 share Decrease -12.70% -3.4K shares -60K $2.58 23.37K
Q1 2022 share Increase +152.07% 16.15K shares 49K $4.48 26.77K
Q4 2021 share Increase +2.66% 275 shares 0 $7.04 10.62K
Q3 2021 share Increase 0.00% 10.34K shares 72K $7.29 10.34K